HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rep. Pallone Galvanized By FDA's 'Troubling Overview' Of Cosmetic Imports

This article was originally published in The Rose Sheet

Executive Summary

FDA physically inspected less than 1% of the 2.9m cosmetic imports that reached the US in fiscal 2016, according to a letter from the agency released by Congressman Frank Pallone. The ranking member of the House Energy and Commerce Committee says he's aiming for a hearing in September on his bipartisan proposal to increase FDA's authority over the cosmetics sector.

Advertisement

Related Content

NGOs Demand Action From Amazon, eBay On Mercury-Containing Skin-Lightening Creams
FDA To Hanbul Cosmetics: You’re Marketing Noncompliant Drugs
Rep. Pallone Has Cosmetics Concerns, Possibly Coming To A Storefront Near You
2017 In Review: FDA's Cosmetics Slowdown Could Bolster Case For Legislative Jumpstart
Rep. Pallone Seeks Answers In Tween Makeup Asbestos Controversy
OTC Monograph Reform Proposal Offers Two-Tier Approach
OTC Monograph User Fees Up To $34M Floated In Senate Discussion Draft
Cosmetics Reform Bill Relaunches In Senate, Sending Stakeholders To Familiar Corners
Pallone Proposes House Companion To PCPSA; Will 2017 Be The Year For Reform?
FDA To Congressman Pallone: Probe Into WEN Conditioner AEs Continues

Topics

Advertisement
UsernamePublicRestriction

Register

RS121119

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel